Department of Pediatrics, University Hospital Motol and Second Faculty of Medicine, Charles University in Prague, Czech Republic.
Inflamm Bowel Dis. 2011 Jul;17(7):1523-9. doi: 10.1002/ibd.21532. Epub 2010 Nov 8.
The role of the IBD5 locus in development of Crohn's disease (CD) has not been clarified. In the Czech population we examined its genetic association using variants of the SLC22A4 (rs1050152), SLC22A5 (rs2631367), two single nucleotide polymorphisms (SNPs) shown to be associated with CD in genome-wide studies (rs6596075 and rs2188962), and four SNPs previously shown to tag the haplotype blocks 4, 7, 9, 10 of the IBD5 locus (IGR2063b_1, IGR2230a_1, IGR100Xa_1, IGR3236a_1).
The genotype, phenotype, and allelic frequencies were compared between 469 unrelated patients with CD (177 pediatric-onset, 292 adult-onset) and 470 unrelated healthy controls, all Caucasians of Czech ancestry.
The most significant difference between patients and controls was found for the SNP rs6596075 (odds ratio [OR] = 0.70 for the G allele; 95% CI 0.52-0.94) in the dominant model and SNP IGR2063b_1 (OR = 1.38 for the G allele; 95% CI 1.14-1.67) in the log-additive model. We found a strong linkage disequilibrium across the IBD5 locus except rs6596075. The haplotype consisting of minor alleles of all tested SNPs except rs6596075 was carried by 31% patients and 23% control subjects (OR = 1.35, 95% CI 1.06-1.72). The association of variants in SLC22A4 and SLC22A5 was dependent on this risk haplotype, while the strong association of the rs6596075 was seemingly independent. In the analysis of subphenotypes we found only an association of the penetrating disease with rs6596075 (OR = 2.13; 95% CI 1.31-3.47).
Our study confirms the importance of IBD5 in determining CD susceptibility, and demonstrates that two independent genetic factors may be responsible for the association observed within this locus.
IBD5 基因座在克罗恩病(CD)发病机制中的作用尚未阐明。在捷克人群中,我们使用 SLC22A4(rs1050152)、SLC22A5(rs2631367)的变体、两个全基因组研究中与 CD 相关的单核苷酸多态性(SNP)(rs6596075 和 rs2188962)以及之前显示标记 IBD5 基因座的四个 SNP 来检测其遗传关联性。4、7、9、10 单倍型块(IGR2063b_1、IGR2230a_1、IGR100Xa_1、IGR3236a_1)。
比较 469 例无亲缘关系的 CD 患者(177 例儿童发病,292 例成人发病)和 470 例无亲缘关系的健康对照者(均为捷克血统的白种人)的基因型、表型和等位基因频率。
患者与对照组之间最显著的差异是 SNP rs6596075(G 等位基因的优势比[OR]为 0.70;95%可信区间为 0.52-0.94)在显性模型和 SNP IGR2063b_1(OR = 1.38,95%CI 为 1.14-1.67)在对数相加模型中。我们发现除 rs6596075 外,IBD5 基因座存在很强的连锁不平衡。除 rs6596075 外,由所有测试 SNP 的次要等位基因组成的单倍型在 31%的患者和 23%的对照组中携带(OR = 1.35,95%CI 为 1.06-1.72)。SLC22A4 和 SLC22A5 变异的关联取决于这种风险单倍型,而 rs6596075 的强关联似乎是独立的。在亚表型分析中,我们仅发现穿透性疾病与 rs6596075 相关(OR = 2.13;95%CI 为 1.31-3.47)。
本研究证实了 IBD5 在决定 CD 易感性中的重要性,并表明两个独立的遗传因素可能是该基因座观察到的关联的原因。